{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:27:20Z","timestamp":1791584840112,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"abstract":"<jats:p>This study aims to explore the impact of insulin resistance and metabolic abnormalities on metabolic changes, inflammatory responses, and pregnancy complications during in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment in women with polycystic ovary syndrome (PCOS). A total of 100 PCOS patients who attended our hospital between February 2022 and February 2024, along with 100 control subjects with natural pregnancies, were included. Blood samples were analyzed for a range of parameters, including sex hormones (luteinizing hormone, follicle-stimulating hormone, estrogen, progesterone, testosterone, and prolactin), glycometabolism (fasting plasma glucose, fasting insulin, and homeostasis model assessment of insulin resistance), liver and kidney function (triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, creatinine, blood urea nitrogen, and uric acid), and inflammatory markers (C-reactive protein, interleukins [IL-2, IL-4, IL-6, IL-8, IL-12, and IL-18]). Changes in metabolic and inflammatory indicators were monitored throughout different pregnancy stages (early, mid, and late), and pregnancy outcomes, neonatal birth weight, and Apgar scores were recorded. The PCOS-IVF\/ICSI group exhibited significantly higher levels of body mass index, systolic blood pressure, menstrual cycle irregularities, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and hormones (luteinizing hormone, follicle-stimulating hormone, estrogen, progesterone, and testosterone) compared to the natural pregnancy group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Pregnancy metabolic analysis showed significantly elevated fasting plasma glucose, fasting insulin, and homeostasis model assessment of insulin resistance indices across all pregnancy stages in the PCOS group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). Inflammatory markers, including C-reactive protein, IL-2, IL-4, IL-6, IL-8, IL-12, and IL-18, were also significantly higher in the PCOS-IVF\/ICSI group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Pregnancy outcome analysis revealed that the PCOS-IVF\/ICSI group had higher rates of miscarriage and pregnancy complications (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05), with no significant difference in preterm birth rates (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.12). Neonatal birth weight and Apgar scores were slightly lower in the PCOS-IVF\/ICSI group compared to the natural pregnancy group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Compared to women with natural pregnancies, the PCOS-IVF\/ICSI group showed increased risks of metabolic disorders, inflammatory responses, and pregnancy complications, with slightly poorer neonatal outcomes, suggesting a higher risk during pregnancy for PCOS patients.<\/jats:p>","DOI":"10.1097\/md.0000000000042481","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:00:56Z","timestamp":1748318456000},"page":"e42481","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A cohort study on the association between metabolic\/inflammatory status and pregnancy complications in PCOS patients after IVF\/ICSI treatment"],"prefix":"10.1097","volume":"104","author":[{"given":"Mengmeng","family":"Du","sequence":"first","affiliation":[{"name":"Yangzhou University, Yangzhou, China"},{"name":"Department of Gynecology And Obstetrics, Taizhou People\u2019s Hospital, Taizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Ge","sequence":"additional","affiliation":[{"name":"Yangzhou University, Yangzhou, China"},{"name":"Department of Gynecology And Obstetrics, Taizhou People\u2019s Hospital, Taizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations From the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome.","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing.","volume":"23","author":"Sadeghi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"2357737","DOI":"10.1080\/07853890.2024.2357737","article-title":"The latest reports and treatment methods on polycystic ovary syndrome.","volume":"56","author":"Stanczak","year":"2024","journal-title":"Ann Med"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0042-1742292","article-title":"Polycystic ovary syndrome in adolescence: challenges in diagnosis and management.","volume":"44","author":"Manique","year":"2022","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12958-022-01007-z","article-title":"Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?","volume":"20","author":"Wang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"1309993","DOI":"10.3389\/fendo.2024.1309993","article-title":"Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF\/ICSI: a retrospective cohort study.","volume":"15","author":"Hu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1183060","DOI":"10.3389\/fendo.2023.1183060","article-title":"Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature.","volume":"14","author":"Wartena","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","article-title":"Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): a comprehensive review.","volume":"12","author":"Di Lorenzo","year":"2023","journal-title":"Curr Nutr Rep"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease.","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms23084334","article-title":"The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome.","volume":"23","author":"Bednarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/humrep\/deab272","article-title":"Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.","volume":"37","author":"Wen","year":"2022","journal-title":"Hum Reprod"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS.","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.16678","article-title":"Regulatory mechanisms of HMGB1 and its receptors in polycystic ovary syndrome-driven gravid uterine inflammation.","volume":"290","author":"Hu","year":"2023","journal-title":"FEBS J"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MED.0000000000000769","article-title":"Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome.","volume":"29","author":"Selen","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"889029","DOI":"10.3389\/fendo.2022.889029","article-title":"Association of polycystic ovary syndrome phenotypes with adverse pregnancy outcomes after in-vitro fertilization\/intracytoplasmic sperm injection.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1038\/s41467-024-49749-1","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"bqab118","DOI":"10.1210\/endocr\/bqab118","article-title":"Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome.","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12967-021-02817-2","article-title":"Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.","volume":"19","author":"Li","year":"2021","journal-title":"J Transl Med"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"960965","DOI":"10.3389\/fpubh.2022.960965","article-title":"The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: a bibliometric analysis.","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cen.14723","article-title":"Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion.","volume":"97","author":"Bahri Khomami","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"615957","DOI":"10.3389\/fendo.2020.615957","article-title":"Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI.","volume":"11","author":"Sun","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13048-024-01576-0","article-title":"Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF\/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome: a systematic review and network meta-analysis.","volume":"17","author":"Lin","year":"2024","journal-title":"J Ovarian Res"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism.","volume":"23","author":"Armanini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13048-023-01321-z","article-title":"The association between systemic immune-inflammation index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study.","volume":"16","author":"Li","year":"2023","journal-title":"J Ovarian Res"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/s41598-024-53958-5","article-title":"Association of dietary inflammatory index with C-reactive protein and interleukin-6 in women with and without polycystic ovarian syndrome.","volume":"14","author":"Azarbayjani","year":"2024","journal-title":"Sci Rep"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"1327849","DOI":"10.3389\/fendo.2024.1327849","article-title":"Causal relationships exist between polycystic ovary syndrome and adverse pregnancy and perinatal outcomes: a Mendelian randomization study.","volume":"15","author":"Ma","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12906-024-04695-9","article-title":"Correlation between acupuncture dose and pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer: a systematic review.","volume":"24","author":"Li","year":"2024","journal-title":"BMC Complement Med Ther"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5582\/ddt.2023.01096","article-title":"Polycystic ovary syndrome and adverse pregnancy outcomes: potential role of decidual function.","volume":"17","author":"Li","year":"2024","journal-title":"Drug Discov Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:01:01Z","timestamp":1748318461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":29,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042481","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}